Sirona Biochem (STU:ZSB) ROCE % : 0.00% (As of Jan. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sirona Biochem ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sirona Biochem's annualized ROCE % for the quarter that ended in Jan. 2024 was 0.00%.

Sirona Biochem ROCE % Historical Data

The historical data trend for Sirona Biochem's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem ROCE % Chart

Sirona Biochem Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

ROCE %

Get a 7-Day Free Trial

-389.88

-177.06

-293.76

-753.31

Sirona Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROCE %	Get a 7-Day Free Trial															-1,479.31	-1,018.36	-334.86	-	-

Sirona Biochem ROCE % Calculation

Sirona Biochem's annualized ROCE % for the fiscal year that ended in Oct. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Oct. 2023 )		(A: Oct. 2022 )		(A: Oct. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Oct. 2023 )		(A: Oct. 2022 )		(A: Oct. 2023 )
	=	-1.617	/	( ( (0.957 - 0.641)	+	(0.713 - 1.289) )	/ 2 )
	=	-1.617	/	( (0.316	+	-0.576)	/ 2 )
	=	-1.617	/	-0.13
	=	1,243.85 %

Sirona Biochem's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	-1.816	/	( ( (0.713 - 1.289)	+	(0.479 - 1.23) )	/ 2 )
	=	-1.816	/	( ( -0.576	+	-0.751 )	/ 2 )
	=	-1.816	/	-0.6635
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

Sirona Biochem (STU:ZSB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sirona Biochem ROCE % Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (STU:ZSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (STU:ZSB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SRBCF:USA ZSB:Germany SBM:Canada

Address

C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3

Website

https://www.sironabiochem.com

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (STU:ZSB) Headlines

No Headlines